Heat shock protein 90 (HSP90) has been recently involved in the wound-healing pathological response that leads to collagen deposition in patients with IPF and its inhibition represents an exciting drug target against the development of pulmonary fibrosis. The gene discussed is HSP90AA1; the disease is idiopathic pulmonary fibrosis.